Azacitidine Injection bulk supplier for pharma manufacturers

Azacitidine Injection 100 mg/vial Suppliers & Bulk Manufacturers

Available Forms: Injectable

Available Strengths: 100 mg/vial

Reference Brands: Vidaza®(EU & US)

Azacitidine 50 mg and 100 mg Vials (brand name Vidaza®) are used in oncology to treat myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). As a hypomethylating agent, Azacitidine works by inhibiting DNA methylation, promoting the reactivation of genes that control blood cell growth. Available as subcutaneous or intravenous injections, it is vital for patients who are ineligible for intensive chemotherapy.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Azacitidine Injection? List it or send an offer →

Product Description:

Azacitidine 50 mg and 100 mg Vials are essential treatments for myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Available under the brand name Vidaza®, Azacitidine is a hypomethylating agent that plays a critical role in restoring normal blood cell production in patients with MDS or AML. It works by inhibiting DNA methylation, leading to the reactivation of growth-controlling genes. Azacitidine is available in subcutaneous and intravenous injection forms in 50 mg and 100 mg vials, and is crucial in oncology B2B portfolios focused on blood cancers and hematologic malignancies.

Azacitidine Injection — third party manufacturing & bulk supply

Azacitidine Injection 100 mg/vial is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Azacitidine Injection is supplied as Injectable — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Azacitidine Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Azacitidine Injection →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Azacitidine Injection is listed as Injectable in 100 mg/vial. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Azacitidine Injection is referenced against Vidaza®(EU & US). Reference brands are shown for identification only and remain the property of their respective trademark owners.